15.02.2016 Views

CANCER

1PMPyU0

1PMPyU0

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Bloodwise 6<br />

Report of the Trustees for the year ended 31 March 2015<br />

Achieving our vision<br />

Every 14 minutes someone in the UK is diagnosed<br />

with blood cancer or a related disorder. That’s almost<br />

38,000 people every year. Although blood cancer<br />

research is one of the most advanced and innovative<br />

parts of science, the fact that there are more than 100<br />

different types of blood cancer makes our job a very<br />

complex one.<br />

ALL HAEMATOLOGICAL<br />

NEOPLASM<br />

EXPECTED NO.<br />

OF CASES<br />

Total 37,990<br />

Although blood cancers mainly affect people over<br />

50, they’re unusual because they can affect anyone<br />

regardless of age and lifestyle.<br />

And because there are so many types of blood cancer,<br />

it’s often not recognised that together they are the<br />

third biggest cancer killer in the UK.<br />

Thanks to research, significant progress has been<br />

made. Today, two thirds of everyone diagnosed with<br />

blood cancer or related pre-cancerous condition will<br />

still be with us in five years’ time. When we started,<br />

very few survived for this long.<br />

There have been many successes. The transformation<br />

in survival for the most common form of childhood<br />

leukaemia from zero in 1960 to 92% (for those taking<br />

part in the latest clinical trials) today; the development<br />

of the first magic bullet therapies in chronic myeloid<br />

leukaemia; the use of monoclonal antibodies in<br />

diagnosis and treatment; and more recently the<br />

development of cell based therapies. These are just<br />

some of the achievements to date.<br />

Our vision is to beat blood cancer and our mission is<br />

to stop people from dying of blood cancer; to make<br />

patients’ lives better; and to stop blood cancers from<br />

happening in the first place.<br />

To achieve this we invest in a robust translational<br />

pipeline of research, in patient services that improve<br />

the experience of patients, on acting as a voice for<br />

patients by campaigning and on generating awareness<br />

and income. We also share our learning and work with<br />

others to achieve results more quickly.<br />

With thanks to HMRN for the statistics shown on<br />

this page hmrn.org/statistics/incidence<br />

Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089<br />

Registered charity 216032 (England & Wales) SC037529 (Scotland)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!